{
    "organizations": [],
    "uuid": "2dd0f3fc81bb1e27e2b57f6b09cf1cbdce57bbba",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aslan-pharmaceuticals-files-for-us/brief-aslan-pharmaceuticals-files-for-u-s-ipo-idUSEMN4BZZA6",
    "ord_in_thread": 0,
    "title": "BRIEF-Aslan Pharmaceuticals Files For U.S. IPO",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Aslan Pharmaceuticals Ltd :\n* ASLAN PHARMACEUTICALS LIMITED FILES FOR U.S. IPO OF UP TO $86.3 MILLION – SEC FILING\n* ASLAN PHARMACEUTICALS LIMITED SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL “ASLN”\n* ASLAN PHARMACEUTICALS LIMITED SAYS LEERINK PARTNERS, PIPER JAFFRAY ARE AMONG UNDERWRITERS TO IPO\n* ASLAN PHARMACEUTICALS LIMITED SAYS BTIG, H.C. WAINWRIGHT & CO, CLSA ARE AMONG UNDERWRITERS TO IPO\n* ASLAN PHARMACEUTICALS LIMITED SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE Source text : ( bit.ly/2ISrDXD )\n ",
    "published": "2018-03-27T04:32:00.000+03:00",
    "crawled": "2018-03-27T11:55:59.060+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "aslan",
        "pharmaceutical",
        "ltd",
        "aslan",
        "pharmaceutical",
        "limited",
        "file",
        "ipo",
        "million",
        "sec",
        "filing",
        "aslan",
        "pharmaceutical",
        "limited",
        "say",
        "intends",
        "apply",
        "ad",
        "listed",
        "nasdaq",
        "global",
        "market",
        "symbol",
        "asln",
        "aslan",
        "pharmaceutical",
        "limited",
        "say",
        "leerink",
        "partner",
        "piper",
        "jaffray",
        "among",
        "underwriter",
        "ipo",
        "aslan",
        "pharmaceutical",
        "limited",
        "say",
        "btig",
        "wainwright",
        "co",
        "clsa",
        "among",
        "underwriter",
        "ipo",
        "aslan",
        "pharmaceutical",
        "limited",
        "say",
        "proposed",
        "ipo",
        "price",
        "estimate",
        "solely",
        "calculating",
        "sec",
        "registration",
        "fee",
        "source",
        "text"
    ]
}